Gallagher Carol Giltner reported gift involving 42,000 derivative units of PMV Pharmaceuticals, Inc. at $0.00 for $0 on Jun 4, 2026

Gift
Form 4 code G. Bona fide gift.
Director
DIR
Filed Jun 5, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
42,000Stock Option (right to buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
0Direct
Trade date
Jun 4, 2026Gift
Filed
Jun 5, 2026, 4:25 PM ET1-day reporting delay
Accession
0001329959-26-000002Code G · Transaction 98848
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Jun 4, 2026Gift42,000$0.00$0Trade 98849
Jun 4, 2026Grant42,000$0.00$0Trade 98847
3 transaction rows in this filing. Joint filers share the same rows.

PMVP price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
PMVP · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Jun 12, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Footnotes in full

F1: Shares subject to the option vest on the earlier of (i) June 4, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders. F2: The securities are held of record by The Gallagher Revocable Trust dated May 10, 2011 for which the reporting person serves as a trustee.